DebasisDasMD

Cardiology • Little Rock, AR

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to view full profile

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Das' full profile

Already have an account?

Office
10100 Kanis Rd
Little Rock, AR 72205
Phone+1 501-255-6000

Fax+1 501-255-6400

Summary

I am a board certified interventional cardiologist, performing coronary and peripheral arterial interventions, PFO and ASD closures.
Also practice general and nuclear cardiology.

Education & Training

University of Louisville School of MedicineFellowship, Interventional Cardiology, 2000 - 2001
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Cardiovascular Disease, 1997 - 2000
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1993 - 1995
Medical College and Hospital KolkataClass of 1985

Certifications & Licensure

AR State Medical License 2001 - 2026
KY State Medical License 2000 - 2002
OH State Medical License 1995 - 2001
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

43 citations
Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
Debasis Das, Jian Hong
European Journal of Medicinal Chemistry. 2019-05-15
27 citations
Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1.
Debasis Das, Lingzhi Xie, Jingbing Wang, Xin Xu, Zonghua Zhang
Bioorganic & Medicinal Chemistry Letters. 2019-02-15
11 citations
In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models.
Debasis Das, Lingzhi Xie, Jingbing Wang, Jingli Shi, Jian Hong
Bioorganic Chemistry. 2020-03-24

Press Mentions

A Conserved Two-Component System Senses Intracellular Iron Levels and Regulates Redox Balance in Mycobacterium SppSeptember 24th, 2024
After Transplant, 13-Year-Old Becomes Youngest Heart Recipient in East IndiaMarch 3rd, 2021
Kolkata: After Transplant, 13-Year-Old Becomes Youngest Heart Recipient in East IndiaMarch 3rd, 2021
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member